1
Hans P. Merkle is professor of pharmaceutics,
Department of Applied BioSciences at the Federal Institute of Technology
Zurich (ETH Zurich), CH-8057 Zurich,
Switzerland hmerkle@pharma.anbi.ethz.ch.
2
Anna Jen is a project leader, Kuros Biosurgery
AG, Gloriastrasse 18a, 8006
Zurich, Switzerland.
A hybrid protein cocrystal of insulin and a lipophilically
modified derivative provides smoother and longer lasting control of glucose
levels.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
